Patent · US Active

Influenza hemagglutinin and neuraminidase variants

US7744901B2 · kind B2 · utility

9Cited by

20References

17Claims

0Family size

Assignees

MedImmune Limited · US
National Institutes of Health, Office of Technology Transfer · US

Inventors

Chin-Fen Yang · San Jose, US
George Kemble · Saratoga, US
Kanta Subbarao · Washington, US
Brian Philip Murphy · Tampa, US

Key dates

Filing date	Jan 15, 2009
Grant date	Jun 29, 2010
Priority date	—
Expiry date	Jan 15, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2760/16171
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Polypeptides, polynucleotides, methods, compositions, and vaccines comprising (avian pandemic) influenza hemagglutinin and neuraminidase variants are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.